glp-1 receptor agonist kidney outcomes semaglutide flow trial 2024 results Effects of on Heart Failure in Diabetes and Chronic Disease in the GLP1 Receptor Agonists vs SGLT2-I
Description
QSC is not responsible for outcomes, interpretations, or conclusions drawn from any studies conducted using these products
BMJ disclaims all liability and responsibility arising from any reliance placed on the content
Glucagon-like peptide-1 receptor agonists and safety in the preconception period
Jastreboff AM, Kushner RF
[DOI] [PubMed] [Google Scholar] 176.Liu, Y., D
